Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study
Purpose The WHO diagnostic criteria underscore the role of bone marrow (BM) morphology
in distinguishing essential thrombocythemia (ET) from early/prefibrotic primary myelofibrosis …
in distinguishing essential thrombocythemia (ET) from early/prefibrotic primary myelofibrosis …
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
J Thiele, HM Kvasnicka, L Müllauer… - Blood, The Journal …, 2011 - ashpublications.org
Controversy persists regarding the role of histopathology in the distinction between essential
thrombocythemia (ET) and early-prefibrotic primary myelofi-brosis (PMF) presenting with …
thrombocythemia (ET) and early-prefibrotic primary myelofi-brosis (PMF) presenting with …
One thousand patients with essential thrombocythemia: the Mayo Clinic experience
N Gangat, O Karrar, A Al-Kali, KH Begna… - Blood cancer …, 2024 - nature.com
We describe 1000 patients with essential thrombocythemia seen at the Mayo Clinic between
1967 and 2023: median age 58 years (18–90), females 63%, JAK2/CALR/MPL-mutated …
1967 and 2023: median age 58 years (18–90), females 63%, JAK2/CALR/MPL-mutated …
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
BS Wilkins, WN Erber, D Bareford… - Blood, The Journal …, 2008 - ashpublications.org
The role of histopathology in the diagnosis of essential thrombocythemia (ET) is
controversial, and there has been little attempt to quantitate interobserver variability …
controversial, and there has been little attempt to quantitate interobserver variability …
Leukocytosis and risk stratification assessment in essential thrombocythemia
A Carobbio, E Antonioli, P Guglielmelli… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Established risk factors for thrombosis in essential thrombocythemia (ET) include
age and previous vascular events. We aimed to refine this risk stratification by adding …
age and previous vascular events. We aimed to refine this risk stratification by adding …
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
H Gisslinger, G Jeryczynski, B Gisslinger, A Wölfler… - Leukemia, 2016 - nature.com
Essential thrombocythemia (ET) is currently diagnosed either by the British Committee of
Standards in Haematology (BCSH) criteria that are predominantly based on exclusion and …
Standards in Haematology (BCSH) criteria that are predominantly based on exclusion and …
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: a multicenter study involving 1607 patients
GG Loscocco, P Guglielmelli, N Gangat… - American journal of …, 2021 - Wiley Online Library
The current retrospective study involving a total of 1607 patients was designed to identify
clinical and molecular variables that were predictive of inferior myelofibrosis‐free survival …
clinical and molecular variables that were predictive of inferior myelofibrosis‐free survival …
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
N Gangat, AP Wolanskyj, RF McClure, CY Li… - Leukemia, 2007 - nature.com
Unlike the case with thrombosis, prognostic models for survival and leukemic transformation
(LT) in essential thrombocythemia (ET) are not available. Among 605 patients with ET seen …
(LT) in essential thrombocythemia (ET) are not available. Among 605 patients with ET seen …
Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic …
M Brousseau, E Parot‐Schinkel, MP Moles… - …, 2010 - Wiley Online Library
Brousseau M, Parot‐Schinkel E, Moles M‐P, Boyer F, Hunault M & Rousselet M‐C (2010)
Histopathology56, 758‐767 Practical application and clinical impact of the WHO …
Histopathology56, 758‐767 Practical application and clinical impact of the WHO …
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group …
F Passamonti, J Thiele, F Girodon… - Blood, The Journal …, 2012 - ashpublications.org
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health
Organization (WHO) classification. We developed a prognostic model to predict survival at …
Organization (WHO) classification. We developed a prognostic model to predict survival at …
相关搜索
- clinical impact essential thrombocythemia
- risk stratification essential thrombocythemia
- fibrotic progression essential thrombocythemia
- disease subtypes essential thrombocythemia
- leukemic transformation essential thrombocythemia
- primary myelofibrosis essential thrombocythemia
- problems and pitfalls essential thrombocythemia
- interobserver reliability essential thrombocythemia
- practical application essential thrombocythemia